Farms.com Home   News

Mosquito season is almost here, is your swine farm ready?

As the U.S. anticipates the annual surge in mosquito populations, pork producers are urged to implement robust control strategies to reduce mosquito populations near swine farms and minimize potential production impacts. Changes in environmental conditions, specifically during high rainfall seasons, may result in increased mosquito populations that can be a risk for emerging disease and other swine production challenges. Through global disease monitoring by the Swine Health Information Center, heightened awareness for mosquito control stems from the recent 2025 re-emergence of Japanese encephalitis virus in Australia, a stark reminder of the potential impact of this mosquito-borne pathogen.

In February 2025, JEV was reported at two piggeries in southern Queensland, Australia, marking the first detections of the virus in AU commercial swine since July 2022. With no cases detected in piggeries during 2023 or 2024, this re-incursion of JEV into Australian piggeries requires close monitoring. Recent detections in mosquito populations in Goondiwindi, Inglewood, and Monto, as well as in mosquito and feral pig populations in New South Wales, have raised concerns about further potential spread of JEV, particularly with wet season conditions increasing mosquito activity.
The U.S. is currently negative for JEV, a mosquito-borne virus which has waterbirds as a natural reservoir host but is capable of infecting pigs, humans and horses. As a transboundary disease risk for U.S. introduction, JEV is transmitted through the bite of infected mosquitos and can cause reproductive failure, delayed farrowing, stillbirths, mummified fetuses, abortions and weak piglets in swine breeding herds. In December 2024, SHIC, along with the Foundation for Food & Agriculture Research, funded six research projects to enhance U.S. prevention, preparedness, mitigation and response capabilities for JEV.

Click here to see more...

Trending Video

How Aurora Pharmaceutical Became a Leader in Animal Health

Video: How Aurora Pharmaceutical Became a Leader in Animal Health

Dr. Michael Strobel, Founder and CEO of Aurora Pharmaceutical, discusses the company's remarkable journey from a veterinarian-led startup to a leading developer and manufacturer of animal health solutions.

In this exclusive interview, Dr. Strobel shares how Aurora Pharmaceutical was built around a simple but powerful mission: putting customers, producers, veterinarians, pet owners, and patients first. Learn how the company has grown by focusing on high-quality, science-backed, and cost-effective solutions for livestock, companion animals, and human health markets.

Discover how Aurora's commitment to innovation, affordability, and customer service continues to drive its expansion across swine, cattle, poultry, equine, companion animal, and human health sectors. Dr. Strobel also discusses the importance of understanding real-world challenges facing producers and veterinarians and how Aurora develops practical solutions that improve animal health while supporting producer profitability. Aurora's veterinarian-founded approach, commitment to American manufacturing, and focus on delivering value have helped establish the company as a trusted partner throughout the animal health industry.